OppenheimerFunds’s ResMed RMD Stock Holding History

OppenheimerFunds’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$79.3M	Buy	762,303 +339,632	+80%	+$35.1M	0.1%	214
2018 Q4	$48.1M	Buy	422,671 +420,598	+20,289%	+$45.1M	0.07%	278
2018 Q3	$239K	Buy	2,073 +17	+0.8%	+$1.86K	﹤0.01%	1742
2018 Q2	$213K	Sell	2,056 -496	-19%	-$50.2K	﹤0.01%	1752
2018 Q1	$251K	Sell	2,552 -1,572	-38%	-$149K	﹤0.01%	1654
2017 Q4	$349K	Buy	+4,124	New	+$341K	﹤0.01%	1645
2017 Q1	–	Sell	-6,450	Closed	-$400K	–	1887
2016 Q4	$400K	Buy	6,450 +1,969	+44%	+$121K	﹤0.01%	1470
2016 Q3	$290K	Buy	4,481 +1	+0%	+$67	﹤0.01%	1508
2016 Q2	$283K	Buy	4,480 +435	+11%	+$25.6K	﹤0.01%	1489
2016 Q1	$234K	Sell	4,045 -768	-16%	-$43.5K	﹤0.01%	1549
2015 Q4	$258K	Buy	+4,813	New	+$271K	﹤0.01%	1577
2015 Q2	–	Sell	-1,726,530	Closed	-$124M	–	962
2015 Q1	$124M	Buy	1,726,530 +1,460,670	+549%	+$94.9M	0.14%	190
2014 Q4	$14.9M	Buy	+265,860	New	+$13.9M	0.02%	660

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OppenheimerFunds's RMD Position: Q1 2019 in Review

OppenheimerFunds increased its ResMed (RMD) stake by 80% in Q1 2019, buying an estimated $35.1M and bringing the position to 762,303 shares worth $79.3M. The position accounts for 0.1% of the portfolio, ranked #214.

OppenheimerFunds first reported a position in RMD in Q4 2014 and has held it in 13 quarters since. The position peaked at $124M in Q1 2015. 477 funds tracked by Wall St. Rank hold RMD as of Q1 2019.

OppenheimerFunds held 762,303 shares of ResMed worth $79.3M as of Q1 2019.
OppenheimerFunds bought 339,632 ResMed shares in Q1 2019, an estimated $35.1M.
ResMed made up 0.1% of OppenheimerFunds's portfolio in Q1 2019, its #214 holding.
OppenheimerFunds first reported a position in ResMed in Q4 2014 and has held it in 13 quarters since.
OppenheimerFunds's ResMed position peaked at $124M in Q1 2015.
477 funds tracked by Wall St. Rank held ResMed as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.